Course: Navigating Lung Cancer Screening: Identifying and Engaging High-Risk Individuals
Released: 2025-01-31
Despite the clear advantages of screening for early-stage, more treatable lung cancer, a surprisingly low percentage of eligible Americans undergo recommended screening. While current guidelines for lung cancer screening are largely consistent, the nuances in interpreting and applying these criteria to the patient in front of you can be perplexing, leading to lower screening rates. Utilizing clinical cases and related questions, faculty educator Carla Lamb, MD, FACP, FCCP (Lahey Hospital & Medical Center), addresses these key points, offering guidance on how to identify high-risk patients suitable for screening. Additionally, it will provide strategies to facilitate shared decision-making with patients, focusing on a comprehensive discussion of the benefits and risks associated with screening.
Upon completion of this activity, participants should be able to:
View Full Course